sulfasalazine has been researched along with Biliary Cirrhosis in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popp, F | 1 |
| Semela, D | 1 |
| von Kempis, J | 1 |
| Mueller, RB | 1 |
| Dzierzewicz, Z | 1 |
| Cwalina, B | 1 |
| Gawlik, B | 1 |
| Wilczok, T | 1 |
| Gonciarz, Z | 1 |
2 other studies available for sulfasalazine and Biliary Cirrhosis
| Article | Year |
|---|---|
Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept.
Topics: Abatacept; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Liver Cirrhosis, Bili | 2018 |
Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract.
Topics: Adenoma; Adult; Anti-Bacterial Agents; Bacteriological Techniques; Biopsy; Colon; Colonic Diseases, | 1997 |